Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 21.37
-0.05 (-0.23%)
Feb 13, 2026, 3:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.46 billion as of February 13, 2026. Its market cap has increased by 38.08% in one year.
Market Cap
2.46B
Enterprise Value
3.72B
Revenue
626.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.37
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.46B, a decrease of -62.57%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.46B | 8.53% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | 6.57B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 2.92B |
| Shanghai Serum Bio-Technology | 2.87B |
| Shanghai Universal Biotech | 2.87B |
| Shandong Sito Bio-technology | 2.83B |
| Jiangsu CoWin Biotech | 2.80B |
| Jilin Jian Yisheng Pharmaceutical | 2.76B |
| Jiangsu Sihuan Bioengineering | 2.68B |
| Guiyang Xintian Pharmaceutical | 2.49B |